What We're Reading: Page 307
Industry reads hand-picked by our editors
Mar 06, 2017
Mar 03, 2017
-
Regulatory Focus
House bill would incentivize drugmakers to 'repurpose' drugs for rare diseases
-
The Guardian
UK pharma firms accused of illegal deals to hike price of life-saving drug
-
Forbes
Oregon's drug price bill is hard to swallow
-
Slate
Henrietta Lacks wasn’t the only woman who unknowingly contributed to medical history
Mar 02, 2017
-
Kaiser Health News
Patient advocacy groups rake In donations from pharma
-
MIT Technology Review
Amyloid-busting drugs for Alzheimer’s keep failing, but so does everything else
-
Philly.com
Teamsters go after drug wholesaler AmerisourceBergen after opioid crisis hits their homes
-
Fortune
Why Trump’s emotional plea for fast drug approvals will split the pharma industry apart
Mar 01, 2017
Feb 28, 2017
-
The New York Times
How to fight a soaring drug price: Innovate
-
Financial Times
Small patient groups hinder progress of clinical trials
-
Los Angeles Times
Are pharmaceutical companies gouging taxpayers? Lawmakers need to find out
-
Fortune
These were big pharma’s biggest winners and losers in 2016
Feb 27, 2017
Feb 24, 2017
-
Bloomberg
Sworn to secrecy, drugstores stay silent as customers overpay
-
Reuters
Advent raises bid in three-way tussle for Stada
-
The Washington Post
Rise in mumps outbreaks prompts U.S. officials to weigh third vaccine dose
-
Forbes
This company with anti-aging drug is secretly preparing for Trump's new FDA